Nath Bio-Genes (India) LtdQ3 FY21
Nath Bio-Genes (India) Ltd Q3 FY21 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹170P/E: 9.6Market Cap: ₹373 CrSector: Agricultural Food & other Products
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
No information is provided regarding the same in the latest conference call.
Margin guidance
No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
No information is provided regarding the same in the latest conference call.
How does Nath Bio-Genes (India) Ltd rank vs peers in Agricultural Food & other Products?
Pro feature1Nath Bio-Genes (India) Ltd
See full Agricultural Food & other Products sector rankings
Want more stocks like Nath Bio-Genes (India) Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio